BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2020 8:19:14 AM | Browse: 840 | Download: 963
 |
Received |
|
2020-01-18 03:40 |
|
Peer-Review Started |
|
2020-01-18 03:41 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-18 22:24 |
|
Revised |
|
2020-05-07 21:32 |
|
Second Decision |
|
2020-05-19 08:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-05-20 06:12 |
|
Articles in Press |
|
2020-05-20 06:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-11 09:48 |
|
Publish the Manuscript Online |
|
2020-06-15 08:19 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Suha Abu khalaf, Abdulmajeed Albarrak, Mohamad Yousef and Veysel Tahan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Suha Abu khalaf, MD, Doctor, Department of Internal Medicine, University of Missouri, 1 Hospital Dr, Columbia, MO 65212, United States. abukhalafs@health.missouri.edu |
| Key Words |
Immunotherapy; Colitis; Melanoma; Case report; Ipilimumab; Hepatitis |
| Core Tip |
Immunotherapy is one of the novel treatments of this century, though it can cause many predicted and unpredicted immune-related side effects. This is a rare case of immunotherapy induced colitis in an otherwise healthy male who was recently diagnosed with melanoma and was started on appropriate immunotherapy treatment. Clinicians should keep in mind the possible immune side effects of immune checkpoint inhibitors as they can develop at any stage, which will help physicians in stopping these medications earlier and avoiding further serious harm. |
| Publish Date |
2020-06-15 08:19 |
| Citation |
Abu Khalaf S, Albarrak A, Yousef M, Tahan V. Immune checkpoint inhibitors induced colitis, stay vigilant: A case report. World J Gastrointest Oncol 2020; 12(6): 699-704 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i6/699.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i6.699 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
